Financial Data and Key Metrics Changes - Canopy Growth ended Q3 with CAD 371 million in cash and cash equivalents, and a net cash position of CAD 146 million, marking a strong financial foundation [4][10] - The company achieved its slimmest Adjusted EBITDA loss to date of CAD 3 million, reflecting improved cost discipline and execution [14] - Q3 cannabis net revenue was CAD 52 million, up 4% year-over-year, with Canadian medical cannabis revenue increasing 15% to CAD 23 million [11][12] Business Line Data and Key Metrics Changes - Canadian medical cannabis net revenue grew 15% year-over-year, marking the sixth consecutive quarter of growth, driven by high-quality patient experiences and engagement [6] - Canadian adult use cannabis revenue increased 8% year-over-year to CAD 23 million, supported by growth in pre-rolls and vapes [12] - Storz & Bickel net revenue grew 45% sequentially to CAD 23 million, driven by strong seasonal sales and the introduction of new products [13] Market Data and Key Metrics Changes - International cannabis sales increased 22% quarter-over-quarter, indicating stabilization and return to growth [12] - The company is focusing on improving execution and laying groundwork for growth in international markets, particularly in Europe [8] Company Strategy and Development Direction - Canopy Growth is focused on elevating the quality of its brands, strengthening product innovation, and improving cultivation efficiency [7][19] - The proposed acquisition of MTL Cannabis is expected to enhance the company's leadership in Canadian medical cannabis and provide high-quality flower supply [5][6] - The company aims to achieve positive Adjusted EBITDA during fiscal 2027, supported by cost-saving initiatives and growth in Canadian cannabis sales [10][16] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's progress, highlighting a stronger balance sheet and growing Canadian cannabis sales [9] - The focus is on unlocking additional value through elevated cultivation, innovative brands, and disciplined execution [9][19] - Management is actively addressing potential impacts from proposed changes to the Veterans Reimbursement Program while maintaining service quality [6][32] Other Important Information - The company completed a CAD 150 million recapitalization to improve liquidity and extend debt maturities to 2031, providing more flexibility for future financing [5][11] - The integration of MTL Cannabis is expected to contribute positively to net revenue, gross margin, and Adjusted EBITDA [16] Q&A Session Summary Question: Expectations for international business growth over the next 12-18 months - Management indicated that they are confident in improving international supply chain capabilities and expanding flower offerings in Europe [21][22] Question: Trends in gross margin expectations for cannabis - Management expects a blended gross margin in the mid- to high 30s, with the MTL acquisition anticipated to be accretive to gross margin [25][26] Question: Clarification on positive Adjusted EBITDA expectations - Management aims for positive Adjusted EBITDA during fiscal 2027, with efforts to achieve this as soon as possible [29] Question: Impact of debt maturities and equity issuance - Management expects reduced utilization of the ATM in the coming quarters due to improved balance sheet position [30] Question: Domestic medical business and veterans reimbursement proposal - Management is actively working to mitigate the impact of proposed reimbursement changes on veterans while maintaining service quality [32][34]

Industry Overview - The U.S. cannabis sector is at a critical inflection point as of February 2026, with improved market sentiment but selective investor interest [1] - Long-term demand for cannabis continues to grow despite price volatility, with state-level legalization expanding and medical programs remaining stable [2] - Profitability is now prioritized over rapid expansion, leading companies to tighten operations and protect margins [3] Company Highlights Trulieve Cannabis Corp. (TCNNF) - Trulieve is a dominant cannabis operator in the U.S., operating a vertically integrated business model across cultivation, processing, distribution, and retail sales [4] - The company has a significant presence in Florida, which serves as its core revenue engine, while also expanding into states like Pennsylvania, Arizona, Maryland, Ohio, and Connecticut [5] - As of early 2026, Trulieve operates over 230 dispensaries nationwide, enhancing brand visibility and customer loyalty [7] - The company focuses on disciplined expansion, targeting profitable markets to remain competitive during industry slowdowns [9] - Financially, Trulieve emphasizes cash flow and balance sheet strength, with stable revenue and healthy gross margins despite pricing pressure [10] - Management has taken steps to address near-term debt obligations, improving liquidity and reducing financial risk [11] - Trulieve continues generating meaningful EBITDA and maintains sufficient cash reserves for selective growth [12] - The company is well-positioned for future growth as regulatory clarity improves [13] Curaleaf Holdings, Inc. (CURLF) - Curaleaf is the largest cannabis company in the U.S. by revenue, operating across numerous states and markets, providing diversification and risk mitigation [13] - The company operates over 160 dispensaries, with a significant retail presence in Florida and strong positions in New Jersey, New York, Arizona, and Illinois [14] - Curaleaf focuses on operational efficiency, optimizing existing assets rather than aggressive expansion, which helps preserve margins [17] - Financially, Curaleaf generates over a billion dollars in annual revenue, with recent trends showing stabilization and improved gross margins [18] - The company is focused on reducing expenses and streamlining operations, with debt management being a priority [19] - While net profitability remains elusive, losses have narrowed, reflecting disciplined spending and operational focus [20] Verano Holdings Corp. (VRNOF) - Verano is a vertically integrated cannabis operator with a footprint in key markets such as Illinois, Florida, New Jersey, Pennsylvania, and Arizona [21] - The company operates retail dispensaries under brands like Zen Leaf and MÜV, maintaining a strategically placed retail network [22] - Verano emphasizes product quality and consistent branding to attract loyal customers, balancing retail growth with operational discipline [24] - Financially, Verano has faced revenue pressure but has focused on cost control to protect margins [25] - The company has significant net losses due to ongoing investments and restructuring costs, but prioritizes operational efficiency [26] - Verano is considered a higher-risk, higher-reward operator, with potential upside if market conditions improve [26]

Core Business Performance - The core Canadian retail business demonstrated strength with same-store sales growth of 5.5%, contributing to a 15% year-over-year growth in the brick-and-mortar segment [1] - High Tide added 27 stores in 2025, reaching a total of 218 locations, and plans to add another 20-30 stores in 2026, targeting over 350 locations long-term [7][8] Financial Highlights - Fourth-quarter revenue rose 19% year-over-year and 10% sequentially, primarily driven by the brick-and-mortar segment, with consolidated gross margin at 26% [3] - Record performance was reported with revenue of CAD 164 million and Adjusted EBITDA of CAD 12.4 million, implying an annualized revenue run rate exceeding CAD 650 million [4][8] - Adjusted EBITDA increased by 51% year-over-year and 17% sequentially, with a record Adjusted EBITDA margin of 9.4% in the brick-and-mortar segment [2] Operational Efficiency - Salaries and wages fell to 11.5% of revenue, the lowest level in nine quarters, while general and administrative expenses were 4.3% of revenue [2] - Annualized revenue per square foot was CAD 1,775 in the quarter, with market share across five provinces increasing to 12% from 11% a year earlier [10] Loyalty and Membership Growth - Cabana Club membership reached 2.5 million, up 45% year-over-year, with a long-term target raised to 3 million members [9] - The Canadian ELITE member count reached 151,000, up 107% year-over-year, indicating increased shopping frequency and larger basket sizes among these members [9] Acquisition Impact - The Remaxion acquisition contributed nearly CAD 10 million in revenue but pressured margins due to inventory and expiry issues, with improvements expected by late Q2/Q3 [6][11] - High Tide is diversifying supply routes beyond Portugal, citing new sourcing strategies that could reduce costs by 30%-40% [14] Cash Flow and Balance Sheet - Free cash flow for Q4 was CAD 1.3 million, with a total of CAD 12.12 million for the full fiscal year, supporting internal funding for store expansion [16] - Total debt stood at CAD 65.5 million, with cash and cash equivalents at CAD 47.9 million and no upcoming maturities for over two years [17] Market Opportunities - The company is exploring partnerships with U.S. operators following an executive order on cannabis rescheduling, while also considering potential CBD-related policy changes that could benefit its U.S. CBD brands [17][18]

Core Viewpoint - Ascend Wellness Holdings, Inc. has opened a new dispensary in Englewood, Ohio, expanding its retail presence in the state's regulated cannabis market, catering to both medical and non-medical customers [1][2]. Group 1: Company Expansion - The new dispensary in Englewood is part of Ascend's strategy to enhance its retail footprint in Ohio, where it already operates multiple locations [2]. - Ascend aims to provide safe access and quality products while focusing on a patient- and customer-centric retail experience [2]. Group 2: Grand Opening and Community Engagement - A grand opening event is scheduled for January 16, inviting local patients, customers, and community members to explore the new facility and learn about Ascend's product offerings [3]. - The dispensary is designed to create an efficient and welcoming shopping experience, featuring a variety of cannabis products from leading brands [4]. Group 3: Product Offering and Customer Engagement - The Englewood dispensary will offer a wide range of cannabis products, including flower, vapes, edibles, and concentrates, with options for in-store or online purchases [4]. - Ascend has introduced a revamped loyalty program, the Ascenders Club, to reward customers for their purchases and in-store deals [5]. Group 4: Operational Details - The Englewood dispensary will operate daily from 8:00 a.m. to 11:00 p.m., serving both medical and non-medical customers [6]. - For further information about Ascend and its dispensaries, customers can visit the company's website [6]. Group 5: Company Overview - Ascend Wellness Holdings, Inc. is a vertically integrated cannabis operator with assets across several states, including Ohio, and produces a curated selection of cannabis products for retail and wholesale [7].

Core Insights - The U.S. cannabis sector is evolving with regulatory momentum, and strong operators are positioning for long-term growth as of January 2026 [1] Group 1: Trulieve Cannabis Corp. - Trulieve Cannabis Corp. is a leading multistate operator with a dominant presence in Florida and over 190 dispensaries nationwide, supporting strong brand recognition and retail traffic [2][4] - The company emphasizes vertical integration and customer loyalty programs, which contribute to strong repeat customer visits and controlled expansion [2][4] - Financially, Trulieve focuses on stability, generating strong quarterly revenue and maintaining high gross margins, while also producing positive operating cash flow and reducing debt [4] Group 2: Curaleaf Holdings, Inc. - Curaleaf Holdings, Inc. operates approximately 150 dispensaries across key markets such as Florida, Massachusetts, New York, and California, with extensive cultivation and processing facilities [6][8] - The company offers a diverse product portfolio and is expanding internationally, which diversifies revenue sources beyond the U.S. market [6][8] - Despite facing pricing competition and regulatory costs, Curaleaf generates positive operating cash flow and is focusing on cost reductions to stabilize profitability [8] Group 3: Cresco Labs Inc. - Cresco Labs Inc. is known for its branded product strategy and operates in high-value U.S. markets, including Illinois and Pennsylvania, with a strong emphasis on wholesale distribution [9][11] - The company's recent financial performance shows stable quarterly revenue and narrowing net losses, indicating potential stabilization despite industry headwinds [11] - Cresco benefits from improving wholesale demand and may gain from potential federal policy developments that could enhance profitability [11]

Core Insights - Tilray Brands, Inc. is a significant player in the cannabis industry, involved in research, cultivation, production, marketing, and distribution of medical cannabis products [1] - The company operates across multiple segments, including Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business, catering to a diverse customer base [1] Price Target and Analyst Sentiment - The consensus price target for Tilray has increased from $4.5 to $10 over the past year, indicating growing optimism among analysts [2] - Analyst John Zamparo from CIBC has set a more conservative price target of $8, reflecting a cautious approach ahead of the company's second-quarter earnings results scheduled for January 8, 2025 [2] Strategic Expansions and Stock Performance - Tilray's strategic expansions and partnerships in the beverage alcohol and wellness sectors have positively influenced stock sentiment [3] - The company's stock value has nearly tripled over the past six months, driven by the anticipation of cannabis reclassification in the United States, which is expected to significantly benefit cannabis growers like Tilray [3] Financial Performance - Recent earnings reports have shown improvements in revenue and profitability, supported by strong sales in both the cannabis and beverage alcohol segments [4] - The financial strength of Tilray is crucial as the cannabis industry continues to grow, driven by increasing consumer demand and the adoption of medical cannabis [4] Product Innovation - Product innovation is a key focus for Tilray, with new offerings such as GMP-certified flowers, oils, vapes, edibles, and topicals [5] - These innovations help Tilray maintain its competitive edge and attract a broader customer base in the evolving cannabis industry [5]

Industry Overview - The U.S. cannabis market is projected to approach $45 billion in sales by 2025, with analysts expecting double-digit annual growth through 2030 [1] - More states are supporting recreational cannabis access, and medical adoption is expanding nationwide [1] - Recent news indicates that President Trump may issue an executive order to reclassify cannabis from Schedule I to Schedule III, which could ease restrictions on research, taxation, and investment [1] Trading Insights - Traders are advised to adopt a disciplined process, utilizing technical analysis to identify momentum before volume surges [2] - Key indicators include moving-average curls, trendline breaks, and heavy bid stacking near support [2] - Position sizing should remain small due to the high volatility associated with penny stocks [2] Company Highlights AYR Wellness Inc. (AYRWF) - AYR Wellness is a multi-state cannabis operator based in Miami, Florida, focusing on medical and adult-use cannabis [6] - The company has a vertically integrated structure with cultivation, processing, and retail operations across several states [6] - Financially, AYR reported stagnant revenue year-over-year, with losses expanding due to increased operational costs and competitive pricing pressure [8] FLUENT (CNTMF) - FLUENT is a vertically integrated cannabis company headquartered in Tampa, Florida, with operations in cultivation, manufacturing, and retail [9] - The company has a significant presence in Florida, New York, and Pennsylvania, operating over thirty dispensaries [9] - Recent financial results showed nearly flat revenue year-over-year, with margins compressed due to pricing mix and processing inefficiencies [10] Curaleaf Holdings Inc. (CURLF) - Curaleaf is one of the largest cannabis retailers in the U.S., with about 150 retail locations and a diverse product offering [12] - The company has seen revenue growth as new adult-use markets opened, although profitability remains uncertain due to high compliance and operational costs [13] - Curaleaf's extensive retail network provides a competitive advantage, positioning the company well for future growth as federal reforms progress [13] Market Sentiment - The cannabis trade in December focuses on positioning rather than certainty, with stocks like AYRWF, CNTMF, and CURLF providing exposure to real dispensaries and revenue [14] - Improving state access and consumer demand could lead to a stronger industry outlook in 2026 [14]

Core Insights - iAnthus Capital Holdings, Inc. has expanded its operations by opening its 25th GrowHealthy dispensary in St. Petersburg, Florida, enhancing access to premium cannabis products for patients [1][4] Company Overview - iAnthus is a vertically integrated cannabis company focused on building premium brands through cultivation, production, and retail operations across the United States [6] - The company’s brand portfolio includes MPX, Anthologie, Black Label, Cheetah, Frūtful, Last Resort, Moodz, Sunshine State, and The Vault [6] New Dispensary Details - The St. Petersburg dispensary features an expanded lineup of premium product brands, including The Vault, MPX, and Sunshine State, providing patients with greater choice and quality [2][3] - The dispensary is designed to create a local feel while ensuring high-quality service and product consistency [3][4] - Located at 4831 34 Street South, the dispensary operates Monday to Saturday from 9:00 a.m. to 8:30 p.m. and Sunday from 9:00 a.m. to 8:00 p.m. [5] Commitment to Patient Experience - The opening of the St. Petersburg location reflects iAnthus' commitment to enhancing patient access and improving the cannabis retail experience in Florida [4] - The company emphasizes a compassionate, educational, and genuine connection with patients, aiming to create a welcoming environment [4]

Core Viewpoint - TerrAscend Corp. has entered into an exclusive licensing agreement with Tyson 2.0 to launch cannabis products in Maryland and Pennsylvania, aiming to expand its market presence and product offerings in these states [1][2]. Company Overview - TerrAscend is a leading cannabis company listed on the TSX, with operations across North America, including Pennsylvania, New Jersey, Maryland, Ohio, and California [3]. - The company operates retail locations such as The Apothecarium and has scaled cultivation, processing, and manufacturing facilities, ensuring high-quality cannabis products for both medical and adult-use markets [3]. Product Launch Details - The partnership will allow TerrAscend to manufacture and distribute a range of products, including premium flower, vapes, and edibles in Maryland, while in Pennsylvania, the offerings will include flower, vapes, concentrates, and troches [2]. - Products are expected to be available in the new year at Apothecarium locations and select dispensaries in both states [3].

Group 1 - A coalition of 25 state attorneys general has requested Shopify to remove its hosting services from websites that are illegally selling vapes [1]